Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS

Clinical trial NCT05451784 · RECRUITING

Trial details

NCT number: NCT05451784
Sponsor: Fundacio Clinic Barcelona
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Triple-Negative Breast Carcinoma

Start date: 2022-07-20
Primary completion: 2025-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.